Ketonemia variability through menstrual cycle in patients undergoing classic ketogenic diet.

GLUT1-DS classic ketogenic diet drug resistant epilepsy epilepsy ketogenic dietary therapies efficacy ketonemia variability menstrual cycle

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2023
Historique:
received: 16 03 2023
accepted: 13 07 2023
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Ketogenic dietary therapies (KDT) are well-established, safe, non-pharmacologic treatments used for children and adults with drug-resistant epilepsy and other neurological disorders. Ketone bodies (KBs) levels are recognized as helpful to check compliance to the KDT and to attempt titration of the diet according to the individualized needs. KBs might undergo inter-individual and intra-individual variability and can be affected by several factors. Possible variations in glycemia and ketone bodies blood levels according to the menstrual cycle have not been systematically assessed yet, but this time window deserves special attention because of hormonal and metabolic related changes. This study aims at searching for subtle changes in KBs blood level during menstrual cycle in female patients undergoing a stable ketogenic diet, by analyzing 3-months daily measurement of ketone bodies blood levels and glucose blood levels throughout the menstrual cycle. We report the preliminary results on six female patients affected by GLUT1DS or drug resistant epilepsy, undergoing a stable classic ketogenic diet. A significant increase in glucose blood levels during menstruation was found in the entire cohort. As far as the ketone bodies blood levels, an inversely proportional trend compared to glycemia was noted. Exploring whether ketonemia variations might occur according to the menstrual cycle is relevant to determine the feasibility of transient preventive diet adjustments to assure a continuative treatment efficacy and to enhance dietary behavior support. clinicaltrials.gov, identifier NCT05234411.

Identifiants

pubmed: 37575326
doi: 10.3389/fnut.2023.1188055
pmc: PMC10413101
doi:

Banques de données

ClinicalTrials.gov
['NCT05234411']

Types de publication

Journal Article

Langues

eng

Pagination

1188055

Informations de copyright

Copyright © 2023 Pasca, Ferraris, Guglielmetti, Varesio, Totaro, Trentani, Marazzi, Brambilla, Ballante, Armeno, Valenzuela, Caraballo, Veggiotti, Tagliabue and De Giorgis.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Child Neurol. 2000 Dec;15(12):787-90
pubmed: 11198492
Neuropharmacology. 2018 May 1;133:233-241
pubmed: 29325899
Seizure. 2010 Jan;19(1):36-9
pubmed: 19962324
Nutrients. 2021 Jun 30;13(7):
pubmed: 34208933
Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):243-51
pubmed: 14769483
Diabetes Care. 1992 Feb;15(2):213-20
pubmed: 1547678
Epilepsy Behav. 2020 Nov;112:107399
pubmed: 32861023
Epilepsia Open. 2018 May 21;3(2):175-192
pubmed: 29881797
Seizure. 2013 Dec;22(10):803-11
pubmed: 23890838
Diabetes Technol Ther. 2007 Apr;9(2):176-82
pubmed: 17425444
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
Exp Mol Med. 2016 Mar 11;48:e219
pubmed: 26964835
Epilepsia. 2008 Nov;49 Suppl 8:46-9
pubmed: 19049586
JAMA Pediatr. 2023 Mar 1;177(3):258-266
pubmed: 36716045
Nutrients. 2019 Jul 19;11(7):
pubmed: 31330987
Epilepsia. 2023 Feb;64(2):284-291
pubmed: 36471628
Seizure. 2015 May;28:18-25
pubmed: 25770028
Eur J Pediatr. 2016 Oct;175(10):1267-76
pubmed: 27586246
Sports Med. 2010 Mar 1;40(3):207-27
pubmed: 20199120
Clin Nutr. 2012 Apr;31(2):246-9
pubmed: 22019282
J Thorac Dis. 2015 Nov;7(11):E537-40
pubmed: 26716051
J Clin Endocrinol Metab. 2010 Dec;95(12):5435-42
pubmed: 20843950
Nutrients. 2020 Sep 24;12(10):
pubmed: 32987704
Epilepsia. 2015 May;56(5):e58-62
pubmed: 25823700
Nutrients. 2020 Jun 19;12(6):
pubmed: 32575586
Diabetes Technol Ther. 2004 Aug;6(4):473-80
pubmed: 15321002
AJNR Am J Neuroradiol. 2018 Jul;39(7):1336-1340
pubmed: 29724763
Am J Emerg Med. 2013 Feb;31(2):464.e1-3
pubmed: 23107348
Nutrients. 2020 Mar 17;12(3):
pubmed: 32192146

Auteurs

Ludovica Pasca (L)

Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Cinzia Ferraris (C)

Department of Public Health, Experimental and Forensic Medicine, Human Nutrition and Eating Disorder Research Center, University of Pavia, Pavia, Italy.
Department of Public Health, Experimental and Forensic Medicine, Ketogenic Metabolic Therapy Laboratory, University of Pavia, Pavia, Italy.

Monica Guglielmetti (M)

Department of Public Health, Experimental and Forensic Medicine, Human Nutrition and Eating Disorder Research Center, University of Pavia, Pavia, Italy.
Department of Public Health, Experimental and Forensic Medicine, Ketogenic Metabolic Therapy Laboratory, University of Pavia, Pavia, Italy.

Costanza Varesio (C)

Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Martina Totaro (M)

Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Claudia Trentani (C)

Department of Public Health, Experimental and Forensic Medicine, Human Nutrition and Eating Disorder Research Center, University of Pavia, Pavia, Italy.
Department of Public Health, Experimental and Forensic Medicine, Ketogenic Metabolic Therapy Laboratory, University of Pavia, Pavia, Italy.

Claudia Marazzi (C)

Department of Public Health, Experimental and Forensic Medicine, Human Nutrition and Eating Disorder Research Center, University of Pavia, Pavia, Italy.
Department of Public Health, Experimental and Forensic Medicine, Ketogenic Metabolic Therapy Laboratory, University of Pavia, Pavia, Italy.

Ilaria Brambilla (I)

Department of Pediatrics, Pediatric Clinic, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

Elena Ballante (E)

Department of Political and Social Sciences, University of Pavia, Pavia, Italy.
BioData Science Center, IRCCS Mondino Foundation, Pavia, Italy.

Marisa Armeno (M)

Department of Nutrition, Ketogenic Therapy Program Coordinator at Hospital Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.

Gabriela Reyes Valenzuela (GR)

Department of Neurology, Hospital Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.

Roberto H Caraballo (RH)

Department of Neurology, Hospital Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.

Pierangelo Veggiotti (P)

Children Hospital Department Scienze biomediche e cliniche, University of Milan, Milan, Italy.

Anna Tagliabue (A)

Department of Public Health, Experimental and Forensic Medicine, Human Nutrition and Eating Disorder Research Center, University of Pavia, Pavia, Italy.
Department of Public Health, Experimental and Forensic Medicine, Ketogenic Metabolic Therapy Laboratory, University of Pavia, Pavia, Italy.

Valentina De Giorgis (V)

Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Classifications MeSH